FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Frederick Meyers

Research Profile

Disorders

Procedures

Geographic Areas

Chemicals & Drugs

Concepts & Ideas

Activities & Behaviors

Drug Evaluation

Physiology

Gene Expression Regulation, Neoplastic

Co-author Network

Publications

TOP 3
Frederick J Meyers; Melissa D Begg; Michael Fleming; Carol Merchant
Strengthening the career development of clinical translational scientist trainees: a consensus statement of the Clinical Translational Science Award (CTSA) Research Education and Career Development Committees.
Malathi Srinivasan; Daniel C West; Clarence Braddock; John B Collins; Robert E Hales; Mark Henderson; Su-Ting T Li; Frederick J Meyers; Daniel D Pratt; Kelley M Skeff; Donald M Hilty
"Teaching as a Competency": competencies for medical educators.
Frederick J Meyers; Claire Pomeroy
Creating the future biomedical research workforce.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Frederick Meyers (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Frederick J Meyers; Melissa D Begg; Michael Fleming; Carol Merchant
Strengthening the career development of clinical translational scientist trainees: a consensus statement of the Clinical Translational Science Award (CTSA) Research Education and Career Development Committees.
Clinical and translational science 2012;5(2):132-7.
2011: Malathi Srinivasan; Daniel C West; Clarence Braddock; John B Collins; Robert E Hales; Mark Henderson; Su-Ting T Li; Frederick J Meyers; Daniel D Pratt; Kelley M Skeff; Donald M Hilty
"Teaching as a Competency": competencies for medical educators.
Academic medicine : journal of the Association of American Medical Colleges 2011;86(10):1211-20.
2011: Frederick J Meyers; Claire Pomeroy
Creating the future biomedical research workforce.
Science translational medicine 2011;3(102):102fs5.
2011: Warren H Tseng; Hui Wang; Xiaowei Yang; Richard J Bold; Steven L Chen; Steve Martinez; Frederick J Meyers; Robert Canter
Nomogram to predict risk of 30-day morbidity and mortality for patients with disseminated malignancy undergoing surgical intervention.
Annals of surgery 2011;254(2):333-8.
2011: Laurence J Heifetz; Scott D Christensen; Ralph W deVere White; Frederick J Meyers
A model for rural oncology.
Journal of oncology practice / American Society of Clinical Oncology 2011;7(3):168-71.
2011: Jennifer N Wu; Frederick J Meyers; Christopher P Evans
Palliative care in urology.
The Surgical clinics of North America 2011;91(2):429-44, x.
2011: Frederick J Meyers; Michael A Carducci; Matthew J Loscalzo; John Linder; Tamara Greasby; Laurel Beckett
Effects of a problem-solving intervention (COPE) on quality of life for patients with advanced cancer on clinical trials and their caregivers: simultaneous care educational intervention (SCEI): linking palliation and clinical trials.
Journal of palliative medicine 2011;14(4):465-73.
2010: Frederick J Meyers
Recombinant innovation and translational science trainees.
Science translational medicine 2010;2(39):39ed5.
2009: Mindy Young-Spint; Yigit Guner; Frederick J Meyers; Philip D Schneider; Vijay P Khatri
Radical palliative surgery: new limits to pursue.
Pediatric surgery international 2009;25(10):917-21.
2009: Jennifer Shuwen Lee; Klea D Bertakis; Frederick J Meyers; Erica Chedin; Alice Tarantal; Kent Anderson; Lars Berglund
Cardiovascular disease in women--challenges deserving a comprehensive translational approach.
Journal of cardiovascular translational research 2009;2(3):251-5.
2009: Andrea T Borchers; Carlo Selmi; Frederick J Meyers; Carl L Keen; M Eric Gershwin
Probiotics and immunity.
Journal of gastroenterology 2009;44(1):26-46.
2008: Kimberly A Hardin; Frederick J Meyers; Samuel Louie
Integrating palliative care in severe chronic obstructive lung disease.
COPD 2008;5(4):207-20.
2008: Valentina Medici; Lorenzo Rossaro; Jacob A Wegelin; Amit Kamboj; Junko Nakai; Kelli Fisher; Frederick J Meyers
The utility of the model for end-stage liver disease score: a reliable guide for liver transplant candidacy and, for select patients, simultaneous hospice referral.
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 2008;14(8):1100-6.
2008: Celestia S Higano; Catherine M Tangen; Wael A Sakr; James Faulkner; Saul E Rivkin; Frederick J Meyers; Maha Hussain; Laurence H Baker; Kenneth J Russell; E David Crawford
Treatment options for muscle-invasive urothelial cancer for patients who were not eligible for cystectomy or neoadjuvant chemotherapy with methotrexate, vinblastine, doxorubicin, and cisplatin: report of Southwest Oncology Group Trial 8733.
Cancer 2008;112(10):2181-7.
2008: Sean Deane; Frederick J Meyers; M Eric Gershwin
On reversing the persistence of memory: hematopoietic stem cell transplant for autoimmune disease in the first ten years.
Journal of autoimmunity 2008;30(3):180-96.
2008: Frederick J Meyers; Amy Lin; William M Sribney; Sergio Aguilar-Gaxiola
Diverse populations can use hospice services appropriately.
The American journal of medicine 2008;121(4):e1-2.
2008: Andrea T Borchers; Anita Krishnamurthy; Carl L Keen; Frederick J Meyers; M Eric Gershwin
The immunobiology of mushrooms.
Experimental biology and medicine (Maywood, N.J.) 2008;233(3):259-76.
2008: Steve Martinez; Anthony S Robbins; Frederick J Meyers; Richard J Bold; Vijay P Khatri; James E Goodnight
Racial and ethnic differences in treatment and survival among adults with primary extremity soft-tissue sarcoma.
Cancer 2008;112(5):1162-8.
2007: Frederick J Meyers; Steven E Weinberger; John P Fitzgibbons; Jeffrey Glassroth; F Daniel Duffy; Charles P Clayton
Redesigning residency training in internal medicine: the consensus report of the Alliance for Academic Internal Medicine Education Redesign Task Force.
Academic medicine : journal of the Association of American Medical Colleges 2007;82(12):1211-9.
2007: John Linder; Frederick J Meyers
Palliative care for prison inmates: "don't let me die in prison".
JAMA : the journal of the American Medical Association 2007;298(8):894-901.
2007: Donna Kalauokalani; Peter Franks; Jennifer Wright Oliver; Frederick J Meyers; Richard Kravitz
Can patient coaching reduce racial/ethnic disparities in cancer pain control? Secondary analysis of a randomized controlled trial.
Pain medicine (Malden, Mass.) 2007;8(1):17-24.
2006: John P Fitzgibbons; Frederick J Meyers
Redesigning training for internal medicine.
Annals of internal medicine 2006;145(11):865-6; author reply 866.
2006: Quy N H Tran; Shiro Urayama; Frederick J Meyers
Endoscopic ultrasound-guided celiac plexus neurolysis for pancreatic cancer pain: a single-institution experience and review of the literature.
The journal of supportive oncology 2006;4(9):460-2, 464; discussion 463-4.
2006: Anthony F Jerant; Rahman Azari; Thomas S Nesbitt; Adrienne Edwards-Goodbee; Frederick J Meyers
The Palliative Care in Assisted Living (PCAL) pilot study: successes, shortfalls, and methodological implications.
Social science & medicine (1982) 2006;62(1):199-207.
2005: Karen M Knops; Malathi Srinivasan; Frederick J Meyers
Patient desires: a model for assessment of patient preferences for care of severe or terminal illness.
Palliative & supportive care 2005;3(4):289-99.
2005: Mark Henderson; Frederick J Meyers; Tod Ibrahim; Lawrence M Tierney
Confronting the brutal facts in health care.
The American journal of medicine 2005;118(10):1061-3.
2005: Joon-ha Ok; Frederick J Meyers; Christopher P Evans
Medical and surgical palliative care of patients with urological malignancies.
The Journal of urology 2005;174(4 Pt 1):1177-82.
2005: Ted Zwerdling; Kevin Hamann; Frederick J Meyers
Extending palliative care is there a role for preventive medicine?
Journal of palliative medicine 2005;8(3):486-9.
2005: Sheila R Enders; Debora A Paterniti; Frederick J Meyers
An approach to develop effective health care decision making for women in prison.
Journal of palliative medicine 2005;8(2):432-9.
2004: Frederick J Meyers; John Linder; Laurel Beckett; Scott Christensen; Joan Blais; David R Gandara
Simultaneous care: a model approach to the perceived conflict between investigational therapy and palliative care.
Journal of pain and symptom management 2004;28(6):548-56.
2004: Cynthia L Martel; Yueju Li; Laurel Beckett; Helen K Chew; Scott Christensen; Angela Davies; Kit S Lam; Derick H Lau; Frederick J Meyers; Robert T O'Donnell; Carol M Richman; Sidney Scudder; Michael Tanaka; Joseph M Tuscano; Jeanna Welborn; Ted Wun; David R Gandara; Primo Lara
An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California.
Cancer journal (Sudbury, Mass.) 2004;10(5):294-300.
2004: Lorenzo Rossaro; Christoph Troppmann; John P McVicar; Michelle Sturges; Kelli Fisher; Frederick J Meyers
A strategy for the simultaneous provision of pre-operative palliative care for patients awaiting liver transplantation.
Transplant international : official journal of the European Society for Organ Transplantation 2004;17(8):473-5.
2004: Primo Lara; Karen Giselle Chee; Jeff Longmate; Christopher Ruel; Frederick J Meyers; Carl R Gray; Regina Gandour-Edwards; Paul H Gumerlock; Przemyslaw Twardowski; James Doroshow; David R Gandara
Trastuzumab plus docetaxel in HER-2/neu-positive prostate carcinoma: final results from the California Cancer Consortium Screening and Phase II Trial.
Cancer 2004;100(10):2125-31.
2004: Mark M Zalupski; Cathryn Rankin; James R Ryan; David R Lucas; Jeffrey H Muler; Keith S Lanier; G Thomas Budd; J Sybil Biermann; Frederick J Meyers; Karen Antman
Adjuvant therapy of osteosarcoma--A Phase II trial: Southwest Oncology Group study 9139.
Cancer 2004;100(4):818-25.
2004: Anthony F Jerant; Rahman Azari; Thomas S Nesbitt; Frederick J Meyers
The TLC model of palliative care in the elderly: preliminary application in the assisted living setting.
Annals of family medicine 2004;2(1):54-60.
2004: Primo Lara; Frederick J Meyers; Lisa Y Law; Nancy A Dawson; Joan Houston; Ignacio Lauder; Martin J Edelman
Platinum-free combination chemotherapy in patients with advanced or metastatic transitional cell carcinoma.
Cancer 2004;100(1):82-8.
2003: Thomas B Crist; Nicholas F LaRusso; Frederick J Meyers; Charles P Clayton; Tod Ibrahim
Centers, institutes, and the future of clinical departments: Part II.
The American journal of medicine 2003;115(9):745-7.
2003: Primo Lara; David I Quinn; Kim Margolin; Frederick J Meyers; Jeff Longmate; Paul Frankel; Philip C Mack; Corinne Turrell; Peter Valk; Jyotsna Rao; Penelope Buckley; Ted Wun; Robert C Gosselin; Irina Galvin; Paul H Gumerlock; Heinz-Josef Lenz; James Doroshow; David R Gandara
SU5416 plus interferon alpha in advanced renal cell carcinoma: a phase II California Cancer Consortium Study with biological and imaging correlates of angiogenesis inhibition.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(13):4772-81.
2003: Tod Ibrahim; John B O'Connell; Nicholas F LaRusso; Frederick J Meyers; Thomas B Crist
Centers, Institutes, and the future of clinical departments: part I.
The American journal of medicine 2003;115(4):337-41.
2003: Carolyn A Wild; Stephen E Wang; David R Gandara; Primo Lara; Frederick J Meyers; Michael Tanaka; Joan Houston; Jun Lauder; Derick H Lau
Population-based maximum tolerated dose of irinotecan and carboplatin.
Oncology (Williston Park, N.Y.) 2003;17(7 Suppl 7):11-6.
2003: Cynthia L Martel; Paul H Gumerlock; Frederick J Meyers; Primo Lara
Current strategies in the management of hormone refractory prostate cancer.
Cancer treatment reviews 2003;29(3):171-87.
2003: Frederick J Meyers; John Linder
Simultaneous care: disease treatment and palliative care throughout illness.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1412-5.
2002: John Linder; Keith Knauf; Sheila R Enders; Frederick J Meyers
Prison hospice and pastoral care services in California.
Journal of palliative medicine 2002;5(6):903-8.
2002: Regina Gandour-Edwards; Primo Lara; Ann K Folkins; Janine M LaSalle; Laurel Beckett; Yueju Li; Frederick J Meyers; Ralph W deVere White
Does HER2/neu expression provide prognostic information in patients with advanced urothelial carcinoma?
Cancer 2002;95(5):1009-15.
2002: John Linder; Sheila R Enders; Elizabeth Craig; Joan Richardson; Frederick J Meyers
Hospice care for the incarcerated in the United States: an introduction.
Journal of palliative medicine 2002;5(4):549-52.
2002: Primo Lara; Frederick J Meyers; Carl R Gray; Regina Gandour-Edwards; Paul H Gumerlock; Caren Kauderer; Garrett Tichauer; Przemyslaw Twardowski; James Doroshow; David R Gandara
HER-2/neu is overexpressed infrequently in patients with prostate carcinoma. Results from the California Cancer Consortium Screening Trial.
Cancer 2002;94(10):2584-9.
2002: Frederick J Meyers
Surgery for emphysema.
The New England journal of medicine 2002;346(11):860-2.
2002: Robert T O'Donnell; Sally J DeNardo; Laird A Miers; Kathleen R Lamborn; David L Kukis; Gerald L DeNardo; Frederick J Meyers
Combined modality radioimmunotherapy for human prostate cancer xenografts with taxanes and 90yttrium-DOTA-peptide-ChL6.
The Prostate 2002;50(1):27-37.
2001: Robert T O'Donnell; Sally J DeNardo; Aina Yuan; Sui Shen; Carol M Richman; Primo Lara; I J Griffith; Desiree S Goldstein; David L Kukis; G S Martinez; Gary R Mirick; Gerald L DeNardo; Frederick J Meyers
Radioimmunotherapy with (111)In/(90)Y-2IT-BAD-m170 for metastatic prostate cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(6):1561-8.
2001: J W Oliver; Richard Kravitz; S H Kaplan; Frederick J Meyers
Individualized patient education and coaching to improve pain control among cancer outpatients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(8):2206-12.
2001: Primo Lara; R Higdon; N Lim; K Kwan; M Tanaka; Derick H Lau; Ted Wun; Jeanna Welborn; Frederick J Meyers; S Christensen; Robert T O'Donnell; Carol M Richman; Sidney Scudder; Joseph M Tuscano; David R Gandara; Kit S Lam
Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(6):1728-33.
2000: Frederick J Meyers; R T O' Donnell
Correspondence re: G. C. de Gast et al., Phase I trial of combined immunotherapy with subcutaneous granulocyte macrophage colony-stimulating factor, low-dose interleukin 2, and interferon alpha in progressive metastatic melanoma and renal cell carcinoma. Clin. Cancer Res., 6: 1267-1272, 2000.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(10):4167.
2000: Robert T O'Donnell; Sally J DeNardo; Gerald L DeNardo; Laird A Miers; Kathleen R Lamborn; David L Kukis; Frederick J Meyers
Efficacy and toxicity of radioimmunotherapy with (90)Y-DOTA-peptide-ChL6 for PC3-tumored mice.
The Prostate 2000;44(3):187-92.
2000: Martin J Edelman; Frederick J Meyers; T R Miller; S G Williams; Regina Gandour-Edwards; Ralph W deVere White
Phase I/II study of paclitaxel, carboplatin, and methotrexate in advanced transitional cell carcinoma: a well-tolerated regimen with activity independent of p53 mutation.
Urology 2000;55(4):521-5.
2000: Eric J Small; M Meyer; M E Marshall; L M Reyno; Frederick J Meyers; R B Natale; PF Lenehan; L Chen; WJ Slichenmyer; Mario A Eisenberger
Suramin therapy for patients with symptomatic hormone-refractory prostate cancer: results of a randomized phase III trial comparing suramin plus hydrocortisone to placebo plus hydrocortisone.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(7):1440-50.
1999: Primo Lara; Hsing-Jien Kung; Paul H Gumerlock; Frederick J Meyers
Molecular biology of prostate carcinogenesis.
Critical reviews in oncology/hematology 1999;32(3):197-208.
1999: Martin J Edelman; David R Gandara; Frederick J Meyers; R Ishii; M O'Mahony; M Uhrich; Ignacio Lauder; Joan Houston; D W Gietzen
Serotonergic blockade in the treatment of the cancer anorexia-cachexia syndrome.
Cancer 1999;86(4):684-8.
1999: Timothy E Albertson; Frederick J Meyers
Cellular drug interaction in the fight against multidrug resistant cancer.
Critical care medicine 1999;27(2):244-5.
1999: Frederick J Meyers
Perspectives on palliative care: a chair of medicine viewpoint.
Journal of palliative medicine 1999;2(4):371-5.
1999: John Linder; J Blais; Sheila R Enders; S E Melberg; Frederick J Meyers
Palliative education: a didactic and experiential approach to teaching end-of-life care.
Journal of cancer education : the official journal of the American Association for Cancer Education 1999;14(3):154-60.
1999: Primo Lara; Frederick J Meyers
Treatment options in androgen-independent prostate cancer.
Cancer investigation 1999;17(2):137-44.
1998: Frederick J Meyers; Paul H Gumerlock; SG Chi; H Borchers; Arline D Deitch; Ralph W deVere White
Very frequent p53 mutations in metastatic prostate carcinoma and in matched primary tumors.
Cancer 1998;83(12):2534-9.
1998: Robert T O'Donnell; Sally J DeNardo; Xu-Bao Shi; Gary R Mirick; Gerald L DeNardo; Linda A Kroger; Frederick J Meyers
L6 monoclonal antibody binds prostate cancer.
The Prostate 1998;37(2):91-7.
1998: C E Geyer; S J Green; C M Moinpour; J O'Sullivan; D K Goodwin; V A Canfield; Frederick J Meyers; C Kent Osborne; S Martino
Expanded phase II trial of paclitaxel in metastatic breast cancer: a Southwest Oncology Group study.
Breast cancer research and treatment 1998;51(2):169-81.
1998: Martin J Edelman; David Siegel; Frederick J Meyers
Follow-up testing after cancer treatment: is it indicated?
The Western journal of medicine 1998;168(6):528-9.
1998: Frederick J Meyers; Ralph W deVere White
Prostate carcinoma: clarification through clinical insight and molecular diagnostics.
The Western journal of medicine 1998;168(6):525.
1998: Philip C Mack; SG Chi; Frederick J Meyers; S L Stewart; Ralph W deVere White; Paul H Gumerlock
Increased RB1 abnormalities in human primary prostate cancer following combined androgen blockade.
The Prostate 1998;34(2):145-51.
1998: Frederick J Meyers; D Lew; Primo Lara; S Williamson; E Marshall; S P Balcerzak; Saul E Rivkin; Wolfram E Samlowski; E D Crawford
Phase II trial of edatrexate in relapsed or refractory germ cell tumors: a Southwest Oncology Group study (SWOG 9124).
Investigational new drugs 1998;16(4):347-51.
1998: Martin J Edelman; Frederick J Meyers; T Grennan; J Lauder; James Doroshow
Phase II trial of pyrazine diazohydroxide in androgen-independent prostate cancer.
Investigational new drugs 1998;16(2):179-82.
1998: Martin J Edelman; David R Gandara; E A Perez; Derick H Lau; Ignacio Lauder; Corinne Turrell; M Uhrich; Frederick J Meyers
Phase I trial of edatrexate plus carboplatin in advanced solid tumors: amelioration of dose-limiting mucositis by ice chip cryotherapy.
Investigational new drugs 1998;16(1):69-75.
1997: Gerald L DeNardo; David L Kukis; Sally J DeNardo; Sui Shen; LF Mausner; Robert T O'Donnell; Kathleen R Lamborn; Frederick J Meyers; Suresh C Srivastava; Laird A Miers
Enhancement of 67Cu-2IT-BAT-LYM-1 therapy in mice with human Burkitt's lymphoma (Raji) using interleukin-2.
Cancer 1997;80(12 Suppl):2576-82.
1997: Martin J Edelman; Frederick J Meyers; Joan Houston; Ignacio Lauder
Phase I trial of paclitaxel, carboplatin, and methotrexate with granulocyte colony-stimulating factor and leucovorin in advanced transitional cell carcinoma.
Seminars in oncology 1997;24(5 Suppl 15):S15-68-S15-71.
1997: Bernard Fisher; Steve Anderson; D Lawrence Wickerham; Arthur DeCillis; NV Dimitrov; Eleftherios P Mamounas; Norman Wolmark; R Pugh; James N Atkins; Frederick J Meyers; Norman S Abramson; J Wolter; R S Bornstein; L Levy; Edward Romond; V Caggiano; M Grimaldi; P Jochimsen; P Deckers
Increased intensification and total dose of cyclophosphamide in a doxorubicin-cyclophosphamide regimen for the treatment of primary breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-22.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(5):1858-69.
1997: Martin J Edelman; Frederick J Meyers; David Siegel
The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis.
Journal of general internal medicine 1997;12(5):318-31.
1997: W Gordon; K Siegmund; T H Stanisic; B McKnight; I T Harris; P R Carroll; J C Paradelo; Frederick J Meyers; Robert A Chapman; F L Meyskens
A study of reproductive function in patients with seminoma treated with radiotherapy and orchidectomy: (SWOG-8711). Southwest Oncology Group.
International journal of radiation oncology, biology, physics 1997;38(1):83-94.
1997: B B Sheppard; David M Follette; Frederick J Meyers
Giant carcinoid tumor of the lung.
The Annals of thoracic surgery 1997;63(3):851-2.
1997: Ralph W deVere White; Frederick J Meyers; SG Chi; S Chamberlain; D Siders; F Lee; S Stewart; Paul H Gumerlock
Human androgen receptor expression in prostate cancer following androgen ablation.
European urology 1997;31(1):1-6.
1996: H Borchers; Frederick J Meyers; Paul H Gumerlock; S L Stewart; Ralph W deVere White
NM23 gene expression in human prostatic carcinomas and benign prostatic hyperplasias: altered expression in combined androgen blockaded carcinomas.
The Journal of urology 1996;155(6):2080-4.
1996: A B Einstein; M Wolf; K R Halliday; G J Miller; M Hafermann; B A Lowe; Frederick J Meyers; J T Leimert; E D Crawford
Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) bladder cancer unsuitable for cystectomy: a phase I/II Southwestern Oncology Group study.
Urology 1996;47(5):652-7.
1995: M E Marshall; M K Wolf; E D Crawford; G R Weiss; F Ahmann; Frederick J Meyers; B Blumenstein; Mario A Eisenberger; A B Einstein
Phase II trial of CHIP for the treatment of advanced, hormonally refractory carcinoma of the prostate. A Southwest Oncology Group Study.
American journal of clinical oncology 1995;18(5):400-2.
1995: Frederick J Meyers
Screening for cancer. Is it worth it?
The Western journal of medicine 1995;163(2):166-8.
1995: Jeanna Welborn; Kenneth J Kopecky; Frederick J Meyers; R Veith; M Shurafa; James Doroshow; Stanley P Balcerzak; F R Appelbaum
Carboplatin infusion in relapsed and refractory acute myeloid leukemia--a Southwest Oncology Group trial.
Leukemia 1995;9(7):1126-9.
1995: Cynthia G Leichman; T R Fleming; F M Muggia; C M Tangen; Bach Ardalan; James Doroshow; Frederick J Meyers; R F Holcombe; G R Weiss; A Mangalik
Phase II study of fluorouracil and its modulation in advanced colorectal cancer: a Southwest Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(6):1303-11.
1995: M E Marshall; M Wolf; E D Crawford; I M Thompson; R Flanigan; S P Balcerzak; Frederick J Meyers
Evaluation of low dose alpha-interferon (Roferon-A) in patients with advanced renal cell carcinoma: a Southwest Oncology Group study.
Cancer biotherapy 1995;10(3):205-9.
1995: Robert T O'Donnell; G Dea; Frederick J Meyers
A phase II trial of concomitant interferon-alpha-2b and granulocyte-macrophage colony-stimulating factor in patients with advanced renal cell carcinoma.
Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy 1995;17(1):58-61.
1994: J R Fishman; Paul H Gumerlock; Frederick J Meyers; Ralph W deVere White
Quantitation of NM23 expression in human prostate tissues.
The Journal of urology 1994;152(1):202-7.
1994: Frederick J Meyers; Paul H Gumerlock
Prostate cancer screening.
Annals of internal medicine 1994;120(12):1052-3.
1994: SG Chi; Ralph W deVere White; Frederick J Meyers; D B Siders; F Lee; Paul H Gumerlock
p53 in prostate cancer: frequent expressed transition mutations.
Journal of the National Cancer Institute 1994;86(12):926-33.
1993: Frederick J Meyers; SG Chi; J R Fishman; Ralph W deVere White; Paul H Gumerlock
p53 mutations in benign prostatic hyperplasia.
Journal of the National Cancer Institute 1993;85(22):1856-8.
1993: Xu-Bao Shi; Paul H Gumerlock; A A Wellman; Claude F Meares; Gerald L DeNardo; Frederick J Meyers; Sally J DeNardo
Rapid PCR construction of a gene containing Lym-1 antibody variable regions.
PCR methods and applications 1993;3(1):46-53.
1993: R B Livingston; J J Crowley; T Thompson; S K Williamson; Frederick J Meyers; T O'Rourke; J R Neefe
Prolonged, alternating chemotherapy for extensive small cell lung cancer. A Southwest oncology Group study.
Cancer 1993;71(11):3509-13.
1993: Ronald M Bukowski; J Young; G Goodman; Frederick J Meyers; B F Issell; J S Sergi; D McLain; G Fyfe; James Finke
Polyethylene glycol conjugated interleukin-2: clinical and immunologic effects in patients with advanced renal cell carcinoma.
Investigational new drugs 1993;11(2-3):211-7.
1993: M E Marshall; M K Wolf; E D Crawford; S Taylor; B Blumenstein; R Flanigan; Frederick J Meyers; H E Hynes; Bart Barlogie; Mario A Eisenberger
Phase II trial of echinomycin for the treatment of advanced renal cell carcinoma. A Southwest Oncology Group study.
Investigational new drugs 1993;11(2-3):207-9.
1992: M R MacKenzie; H Wold; C George; David R Gandara; G Ray; S Schiff; J Shields; R Artim; H Davidson; Frederick J Meyers
Consolidation hemibody radiotherapy following induction combination chemotherapy in high-tumor-burden multiple myeloma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1992;10(11):1769-74.
1992: R Daifuku; K Haenftling; J Young; E S Groves; C Turrell; Frederick J Meyers
Phase I study of antilipopolysaccharide human monoclonal antibody MAB-T88.
Antimicrobial agents and chemotherapy 1992;36(10):2349-51.
1992: Frederick J Meyers; B Blumenstein; E D Crawford; H E Hynes; James E Montie; S A Taylor; H B Grossman; R B Natale
Combination cisplatin and dichloromethotrexate in patients with advanced bladder cancer. Phase 2. A Southwest Oncology Group study.
The Journal of urology 1992;148(1):52-4.
1992: Y Shih; M W Konrad; M K Warren; A Childs; C Paradise; Frederick J Meyers; E S Groves
Suppression and transient induction of lymphokines in cancer patients after administration of polyethylene glycolated interleukin-2.
European journal of immunology 1992;22(3):727-33.
1992: Ralph W deVere White; Frederick J Meyers; S E Soares; D G Miller; T F Soriano
Urinary prostate specific antigen levels: role in monitoring the response of prostate cancer to therapy.
The Journal of urology 1992;147(3 Pt 2):947-51.
1991: Paul H Gumerlock; YJ Tang; Frederick J Meyers; Joseph Silva
Use of the polymerase chain reaction for the specific and direct detection of Clostridium difficile in human feces.
Reviews of infectious diseases 1991;13(6):1053-60.
1991: Frederick J Meyers; Paul H Gumerlock; E S Kawasaki; A M Wang; Ralph W deVere White; Henry A Erlich
Bladder cancer. Human leukocyte antigen II, interleukin-6, and interleukin-6 receptor expression determined by the polymerase chain reaction.
Cancer 1991;67(8):2087-95.
1991: Paul H Gumerlock; U R Poonamallee; Frederick J Meyers; Ralph W deVere White
Activated ras alleles in human carcinoma of the prostate are rare.
Cancer research 1991;51(6):1632-7.
1991: Frederick J Meyers; C Paradise; S A Scudder; G Goodman; M Konrad
A phase I study including pharmacokinetics of polyethylene glycol conjugated interleukin-2.
Clinical pharmacology and therapeutics 1991;49(3):307-13.
1991: Jeanna Welborn; Frederick J Meyers
A three-point approach to anemia.
Postgraduate medicine 1991;89(2):179-83, 186.
1990: P Palmer; Frederick J Meyers
An outpatient approach to the delivery of intensive consolidation chemotherapy to adults with acute lymphoblastic leukemia.
Oncology nursing forum 1990;17(4):553-8.
1990: David R Gandara; E A Perez; H Wold; V Caggiano; M Malec; D K Ahn; Frederick J Meyers; R W Carlson
High-dose cisplatin and mitomycin C in advanced non-small cell lung cancer: a phase II study of the Northern California Oncology Group.
Cancer chemotherapy and pharmacology 1990;27(3):243-7.
1989: Frederick J Meyers; B R Madewell; Paul H Gumerlock; James DeMartini
ras p21 expression in ovine pulmonary carcinoma.
Veterinary immunology and immunopathology 1989;23(3-4):279-91.
1989: Frederick J Meyers; Paul H Gumerlock; R L Teplitz; S L Hatcher; Ralph W deVere White
Sequential flow cytometry and single gene analysis by enzymatic amplification and allele specific oligonucleotide hybridization of urothelial cells.
The Journal of urology 1989;142(6):1599-601.
1989: Bruce R Madewell; Paul H Gumerlock; K A Saunders; Frederick J Meyers; SA Kraegel; E S Kawasaki
Canine and bovine ras family expression detected and discriminated by use of polymerase chain reaction.
Anticancer research 1989;9(6):1743-9.
1989: DP Link; B M Lantz; J Anthony Seibert; Frederick J Meyers
Partial splenic embolization guided by blood flow measurements.
Investigative radiology 1989;24(9):678-83.
1989: Paul H Gumerlock; Frederick J Meyers; S P Kokoris; G Wong; F P McCormick; Ralph W deVere White
RAS enzyme-linked immunoblot assay discriminates p21 species: a technique to dissect gene family expression.
Analytical biochemistry 1989;180(1):158-68.
1989: D W Carlisle; K A Smith; E Frank; Frederick J Meyers
Intraventricular morphine administered by hospice nurses to a patient with intractable pain.
The American journal of hospice care 1989;6(4):36-9.
1989: Frederick J Meyers; Paul H Gumerlock; S P Kokoris; Ralph W deVere White; F McCormick
Human bladder and colon carcinomas contain activated ras p21. Specific detection of twelfth codon mutants.
Cancer 1989;63(11):2177-81.
1989: David R Gandara; H Wold; E A Perez; A B Deisseroth; James Doroshow; Frederick J Meyers; K McWhirter; J Hannigan; Michael W DeGregorio
Cisplatin dose intensity in non-small cell lung cancer: phase II results of a day 1 and day 8 high-dose regimen.
Journal of the National Cancer Institute 1989;81(10):790-4.
1989: Paul H Gumerlock; Frederick J Meyers; B A Foster; T G Kawakami; Ralph W deVere White
Activated c-N-ras in radiation-induced acute nonlymphocytic leukemia: twelfth codon aspartic acid.
Radiation research 1989;117(2):198-206.
1989: Frederick J Meyers; Jeanna Welborn; J P Lewis; N Flynn
Infusion carboplatin treatment of relapsed and refractory acute leukemia: evidence of efficacy with minimal extramedullary toxicity at intermediate doses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(2):173-8.
1989: Frederick J Meyers; S J Denardo; D Macey; Ralph W deVere White; M Unger
Development of monoclonal antibody imaging of metastatic prostatic carcinoma.
The Prostate 1989;14(3):209-20.
1988: Jeanna Welborn; J P Lewis; Frederick J Meyers
Impact of reinduction regimens on the clinical course of adult acute nonlymphocytic leukemia.
Leukemia 1988;2(11):711-6.
1988: Frederick J Meyers; Jeanna Welborn; J P Lewis
Improved approach to patients with normocytic anemia.
American family physician 1988;38(2):191-5.
1988: Robert Cardiff; Paul H Gumerlock; M M Soong; Satya Dandekar; Peter A Barry; L J Young; Frederick J Meyers
c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors.
Oncogene 1988;3(2):205-13.
1988: Paul H Gumerlock; B F Edwards; Arline D Deitch; Frederick J Meyers
Human renal clear cell carcinoma: establishment and characterization of a new cell line (G-2101).
In vitro cellular & developmental biology : journal of the Tissue Culture Association 1988;24(5):429-34.
1988: Jeanna Welborn; Frederick J Meyers; L F O'Grady
Renal salt wasting and carboplatinum.
Annals of internal medicine 1988;108(4):640.
1988: F M Torti; L D Shortliffe; R D Williams; W C Pitts; R L Kempson; J C Ross; J Palmer; Frederick J Meyers; M Ferrari; J Hannigan
Alpha-interferon in superficial bladder cancer: a Northern California Oncology Group Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1988;6(3):476-83.
1988: W C Baker; Frederick J Meyers; Ralph W deVere White
Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with metastatic prostate cancer.
Journal of surgical oncology 1988;37(3):165-7.
1987: Frederick J Meyers; F H Meyers
Management of chronic pain.
American family physician 1987;36(1):139-46.
1987: A P Venook; A Tseng; Frederick J Meyers; I Silverberg; R Boles; Karen K Fu; C D Jacobs
Cisplatin, doxorubicin, and 5-fluorouracil chemotherapy for salivary gland malignancies: a pilot study of the Northern California Oncology Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1987;5(6):951-5.
1987: H Y Chan; Frederick J Meyers; J P Lewis
High-dose VP-16 with intermediate-dose cytosine arabinoside in the treatment of relapsed acute nonlymphocytic leukemia.
Cancer chemotherapy and pharmacology 1987;20(3):265-6.
1987: J P Lewis; Jeanna Welborn; Frederick J Meyers; N B Levy; T Roschak
Mast cell disease followed by leukemia with clonal evolution.
Leukemia research 1987;11(9):769-73.
1986: Frederick J Meyers; J P Lewis; S Marianos
The integration of cytogenetic analysis into the evaluation of cryptic exudative effusions.
Cancer 1986;58(7):1479-83.
1986: Frederick J Meyers; J P Lewis
A focused approach to patients with cancer of unknown primary site.
The Western journal of medicine 1986;145(3):403-4.
1986: Frederick J Meyers; James E Goodnight
Identification of unsuspected thyroid carcinoma using immunoperoxidase for thyroglobulin.
The American journal of medicine 1986;81(1):177-9.
1986: F M Torti; M M Bristow; B L Lum; S K Carter; A E Howes; D A Aston; B W Brown; J F Hannigan; Frederick J Meyers; E P Mitchell
Cardiotoxicity of epirubicin and doxorubicin: assessment by endomyocardial biopsy.
Cancer research 1986;46(7):3722-7.
1986: Frederick J Meyers; Robert Cardiff; R Quadro; M Gribble; M Kohler; V Medrano; E P Mitchell; R Shiffman; L William
Epirubicin in non-oat cell lung cancer--response rates and the importance of immunopathology: a Northern California Oncology Group Study.
Cancer treatment reports 1986;70(6):805-6.
1986: Frederick J Meyers
Tumor biology in explanation of the failure of screening for cancer and in determination of future strategies.
The American journal of medicine 1986;80(5):911-6.
1986: Frederick J Meyers; C H Miller; J P Lewis
The resolution of phenotypic ambiguity in a case of human leukemia using cytogenetics and immunoglobulin gene rearrangement.
American journal of clinical pathology 1986;85(3):372-4.
1986: J I Bernstein; C Jacobs; Frederick J Meyers; L Rich-Goffinet; L Tanaka
A phase II study of cisplatin and cytosine arabinoside for recurrent squamous cell carcinoma of the head and neck.
American journal of clinical oncology 1986;9(1):58-60.
1985: Frederick J Meyers; J M Palmer; F S Freiha; E G Harker; L D Shortliffe; J Hannigan; K McWhirter; F M Torti
The fate of the bladder in patients with metastatic bladder cancer treated with cisplatin, methotrexate and vinblastine: a Northern California Oncology Group study.
The Journal of urology 1985;134(6):1118-21.
1985: W G Harker; Frederick J Meyers; F S Freiha; J M Palmer; L D Shortliffe; J F Hannigan; K M McWhirter; F M Torti
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(11):1463-70.
1985: J P Lewis; Frederick J Meyers; L Tanaka
Daunomycin administered by continuous intravenous infusion is effective in the treatment of acute nonlymphocytic leukaemia.
British journal of haematology 1985;61(2):261-5.
1985: J P Lewis; Frederick J Meyers
Chronic myelogenous leukemia and breaks at 9q34.
Cancer genetics and cytogenetics 1985;17(4):367-8.
1985: Frederick J Meyers; B Lewis; E Mitchell; L William; J F Hannigan; M Gribble; F M Torti
Phase II trial of 4'-epi-doxorubicin in advanced colorectal carcinoma: a Northern California Oncology Group study.
Cancer treatment reports 1985;69(1):143-4.
1984: F M Torti; K J Porzig; David R Gandara; P Volberding; E Mitchell; Frederick J Meyers; M Kohler; M Gribble
Phase II trial of 4'-epi-doxorubicin in metastatic melanoma.
Cancer treatment reports 1984;68(12):1509-10.
1984: Frederick J Meyers; Robert Cardiff; C R Taylor; M Zuniga; J Radich
Hairy cell leukemia has a B-cell genotype.
Hematological oncology 1984;2(2):145-50.
1983: C Jacobs; Frederick J Meyers; C Hendrickson; M Kohler; S Carter
A randomized phase III study of cisplatin with or without methotrexate for recurrent squamous cell carcinoma of the head and neck. A Northern California Oncology Group study.
Cancer 1983;52(9):1563-9.
1983: Frederick J Meyers
Penile cancer chemotherapy.
Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer 1983;85():143-7.
1982: Frederick J Meyers; J P Lewis; S Marianos
Case 42-1981: Hodgkin's disease.
The New England journal of medicine 1982;306(18):1115.